{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:36:28Z","timestamp":1792247788262,"version":"4.4.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K08AG051187"],"award-info":[{"award-number":["K08AG051187"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062713"],"award-info":[{"award-number":["R01AG062713"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG071809"],"award-info":[{"award-number":["R01AG071809"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24AG073527"],"award-info":[{"award-number":["K24AG073527"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s40266-024-01121-0","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T08:01:45Z","timestamp":1719907305000},"page":"583-600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7290-6838","authenticated-orcid":false,"given":"Dae Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Mi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darae","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kueiyu Joshua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"issue":"11","key":"1121_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40266-015-0324-3","volume":"32","author":"A Marengoni","year":"2015","unstructured":"Marengoni A, Nobili A, Onder G. Best practices for drug prescribing in older adults: a call for action. Drugs Aging. 2015;32(11):887\u201390.","journal-title":"Drugs Aging"},{"issue":"10","key":"1121_CR2","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1681\/ASN.2019030238","volume":"30","author":"P Delanaye","year":"2019","unstructured":"Delanaye P, Jager KJ, Bokenkamp A, Christensson A, Dubourg L, Eriksen BO, et al. CKD: A call for an age-adapted definition. J Am Soc Nephrol. 2019;30(10):1785\u2013805.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1121_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2165\/00002512-199405010-00004","volume":"5","author":"FL Iber","year":"1994","unstructured":"Iber FL, Murphy PA, Connor ES. Age-related changes in the gastrointestinal system. Effects on drug therapy. Drugs Aging. 1994;5(1):34\u201348.","journal-title":"Drugs Aging"},{"issue":"6","key":"1121_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jama.294.6.716","volume":"294","author":"CM Boyd","year":"2005","unstructured":"Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716\u201324.","journal-title":"JAMA"},{"issue":"27","key":"1121_CR5","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1056\/NEJMsb042458","volume":"351","author":"ME Tinetti","year":"2004","unstructured":"Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870\u20134.","journal-title":"N Engl J Med"},{"issue":"9868","key":"1121_CR6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752\u201362.","journal-title":"Lancet"},{"issue":"1","key":"1121_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12916-020-01752-1","volume":"18","author":"P Hanlon","year":"2020","unstructured":"Hanlon P, Butterly E, Lewsey J, Siebert S, Mair FS, McAllister DA. Identifying frailty in trials: an analysis of individual participant data from trials of novel pharmacological interventions. BMC Med. 2020;18(1):309.","journal-title":"BMC Med"},{"issue":"10","key":"1121_CR8","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/jgs.18481","volume":"71","author":"YC Lee","year":"2023","unstructured":"Lee YC, Lin JK, Ko D, Cheng S, Patorno E, Glynn RJ, et al. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction. J Am Geriatr Soc. 2023;71(10):3110\u201321.","journal-title":"J Am Geriatr Soc"},{"key":"1121_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.amjcard.2023.08.059","volume":"207","author":"D Ko","year":"2023","unstructured":"Ko D, Pande A, Lin KJ, Cervone A, Bessette LG, Lee SB, et al. Utilization of P2Y(12) inhibitors in older adults with ST-elevation myocardial infarction and frailty. Am J Cardiol. 2023;207:245\u201352.","journal-title":"Am J Cardiol"},{"issue":"11","key":"1121_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.42964","volume":"5","author":"D Ko","year":"2022","unstructured":"Ko D, Lin KJ, Bessette LG, Lee SB, Walkey AJ, Cheng S, et al. Trends in use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, 2010\u20132020. JAMA Netw Open. 2022;5(11): e2242964.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"1121_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40266-013-0095-7","volume":"30","author":"HM Holmes","year":"2013","unstructured":"Holmes HM, Min LC, Yee M, Varadhan R, Basran J, Dale W, Boyd CM. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging. 2013;30(9):655\u201366.","journal-title":"Drugs Aging"},{"issue":"3","key":"1121_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014686","volume":"9","author":"MAM Farooqi","year":"2020","unstructured":"Farooqi MAM, Gerstein H, Yusuf S, Leong DP. Accumulation of deficits as a key risk factor for cardiovascular morbidity and mortality: a pooled analysis of 154 000 individuals. J Am Heart Assoc. 2020;9(3): e014686.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"1121_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/eurheartj\/ehab850","volume":"43","author":"W Shrauner","year":"2022","unstructured":"Shrauner W, Lord EM, Nguyen XT, Song RJ, Galloway A, Gagnon DR, et al. Frailty and cardiovascular mortality in more than 3 million US Veterans. Eur Heart J. 2022;43(8):818\u201326.","journal-title":"Eur Heart J"},{"issue":"4","key":"1121_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/ageing\/afab003","volume":"50","author":"SN Hilmer","year":"2021","unstructured":"Hilmer SN, Kirkpatrick CMJ. New Horizons in the impact of frailty on pharmacokinetics: latest developments. Age Ageing. 2021;50(4):1054\u201363.","journal-title":"Age Ageing"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mad.2019.111119","volume":"181","author":"SN Hilmer","year":"2019","unstructured":"Hilmer SN, Wu H, Zhang M. Biology of frailty: Implications for clinical pharmacology and drug therapy in frail older people. Mech Ageing Dev. 2019;181:22\u20138.","journal-title":"Mech Ageing Dev"},{"issue":"12","key":"1121_CR16","doi-asserted-by":"publisher","first-page":"e724","DOI":"10.1016\/S2666-7568(23)00208-8","volume":"4","author":"M Denkinger","year":"2023","unstructured":"Denkinger M, Knol W, Cherubini A, Simonds A, Lionis C, Lacombe D, et al. Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults. Lancet Healthy Longev. 2023;4(12):e724\u20139.","journal-title":"Lancet Healthy Longev."},{"key":"1121_CR17","doi-asserted-by":"publisher","unstructured":"Hilmer SN, Schwartz J, Petrovic M, Walker LE, Thurmann P, Le Couteur DG. Addressing the gaps in evaluation of new drugs for older adults: strategies from the International Union of Basic and Clinical Pharmacology (IUPHAR) Geriatric Committee. J Am Geriatr Soc. 2024. https:\/\/doi.org\/10.1111\/jgs.18826. Epub\nahead of print. PMID: 38485461","DOI":"10.1111\/jgs.18826"},{"issue":"9","key":"1121_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/pds.3674","volume":"23","author":"DH Kim","year":"2014","unstructured":"Kim DH, Schneeweiss S. Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations. Pharmacoepidemiol Drug Saf. 2014;23(9):891\u2013901.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1121_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4235\/agmr.20.0002","volume":"24","author":"DH Kim","year":"2020","unstructured":"Kim DH. Measuring frailty in health care databases for clinical care and research. Ann Geriatr Med Res. 2020;24(2):62\u201374.","journal-title":"Ann Geriatr Med Res."},{"key":"1121_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104102","volume":"89","author":"S Nghiem","year":"2020","unstructured":"Nghiem S, Sajeewani D, Henderson K, Afoakwah C, Byrnes J, Moyle W, Scuffham P. Development of frailty measurement tools using administrative health data: a systematic review. Arch Gerontol Geriatr. 2020;89: 104102.","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"1121_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/MLR.0000000000001359","volume":"58","author":"SA Shashikumar","year":"2020","unstructured":"Shashikumar SA, Huang K, Konetzka RT, Joynt Maddox KE. Claims-based frailty indices: a systematic review. Med Care. 2020;58(9):815\u201325.","journal-title":"Med Care"},{"key":"1121_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104612","volume":"99","author":"A Lim","year":"2022","unstructured":"Lim A, Choi J, Ji H, Lee H. Frailty assessment using routine clinical data: an integrative review. Arch Gerontol Geriatr. 2022;99: 104612.","journal-title":"Arch Gerontol Geriatr"},{"key":"1121_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.901068","volume":"10","author":"J Luo","year":"2022","unstructured":"Luo J, Liao X, Zou C, Zhao Q, Yao Y, Fang X, Spicer J. Identifying frail patients by using electronic health records in primary care: current status and future directions. Front Public Health. 2022;10: 901068.","journal-title":"Front Public Health"},{"key":"1121_CR24","doi-asserted-by":"publisher","unstructured":"Brack C, Kynn M, Murchie P, Makin S. Validated frailty measures using electronic primary care records: a review of diagnostic test accuracy. Age Ageing. 2023;52(11)afad173. https:\/\/doi.org\/10.1093\/ageing\/afad173. PMID:\n37993406; PMCID: PMC10873280.","DOI":"10.1093\/ageing\/afad173"},{"issue":"1","key":"1121_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jgo.2012.08.004","volume":"4","author":"L Hempenius","year":"2013","unstructured":"Hempenius L, Slaets JP, Boelens MA, van Asselt DZ, de Bock GH, Wiggers T, van Leeuwen BL. Inclusion of frail elderly patients in clinical trials: solutions to the problems. J Geriatr Oncol. 2013;4(1):26\u201331.","journal-title":"J Geriatr Oncol."},{"key":"1121_CR26","doi-asserted-by":"publisher","unstructured":"Pitkala KH, Strandberg TE. Clinical trials in older people. Age Ageing. 2022;51(5):afab282. https:\/\/doi.org\/10.1093\/ageing\/afab282. PMID: 35526845; PMCID: PMC9080968.","DOI":"10.1093\/ageing\/afab282"},{"issue":"1","key":"1121_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/ageing\/afu157","volume":"44","author":"A Clegg","year":"2015","unstructured":"Clegg A, Rogers L, Young J. Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing. 2015;44(1):148\u201352.","journal-title":"Age Ageing"},{"issue":"1","key":"1121_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s43587-020-00017-z","volume":"1","author":"LP Fried","year":"2021","unstructured":"Fried LP, Cohen AA, Xue QL, Walston J, Bandeen-Roche K, Varadhan R. The physical frailty syndrome as a transition from homeostatic symphony to cacophony. Nat Aging. 2021;1(1):36\u201346.","journal-title":"Nat Aging."},{"issue":"3","key":"1121_CR29","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146\u201356.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1121_CR30","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s43587-021-00099-3","volume":"1","author":"SE Howlett","year":"2021","unstructured":"Howlett SE, Rutenberg AD, Rockwood K. The degree of frailty as a translational measure of health in aging. Nat Aging. 2021;1:651\u201365.","journal-title":"Nat Aging."},{"key":"1121_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1100\/tsw.2001.58","volume":"1","author":"AB Mitnitski","year":"2001","unstructured":"Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323\u201336.","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"1121_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/gerona\/62.7.738","volume":"62","author":"K Rockwood","year":"2007","unstructured":"Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738\u201343.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"1121_CR33","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/jgs.18453","volume":"71","author":"SDM Sison","year":"2023","unstructured":"Sison SDM, Shi SM, Kim KM, Steinberg N, Jeong S, McCarthy EP, Kim DH. A crosswalk of commonly used frailty scales. J Am Geriatr Soc. 2023;71(10):3189\u201398.","journal-title":"J Am Geriatr Soc"},{"key":"1121_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.","journal-title":"BMC Geriatr"},{"key":"1121_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","volume":"13","author":"J Warwick","year":"2015","unstructured":"Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78.","journal-title":"BMC Med"},{"key":"1121_CR36","doi-asserted-by":"publisher","unstructured":"Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years: A Randomized Clinical Trial. JAMA. 2016;315(24):2673-82. https:\/\/doi.org\/10.1001\/jama.2016.7050. PMID:\n27195814; PMCID: PMC4988796","DOI":"10.1001\/jama.2016.7050"},{"issue":"11","key":"1121_CR37","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/ejhf.1308","volume":"20","author":"NA Sanders","year":"2018","unstructured":"Sanders NA, Supiano MA, Lewis EF, Liu J, Claggett B, Pfeffer MA, et al. The frailty syndrome and outcomes in the TOPCAT trial. Eur J Heart Fail. 2018;20(11):1570\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"1121_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","volume":"18","author":"C Wilkinson","year":"2020","unstructured":"Wilkinson C, Wu J, Searle SD, Todd O, Hall M, Kunadian V, et al. Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial. BMC Med. 2020;18(1):401.","journal-title":"BMC Med"},{"issue":"6","key":"1121_CR39","doi-asserted-by":"publisher","first-page":"820","DOI":"10.7326\/M21-4776","volume":"175","author":"JH Butt","year":"2022","unstructured":"Butt JH, Dewan P, Merkely B, Belohlavek J, Drozdz J, Kitakaze M, et al. Efficacy and safety of dapagliflozin according to frailty in heart failure with reduced ejection fraction\u202f: a post hoc analysis of the DAPA-HF Trial. Ann Intern Med. 2022;175(6):820\u201330.","journal-title":"Ann Intern Med"},{"issue":"16","key":"1121_CR40","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1161\/CIRCULATIONAHA.122.061754","volume":"146","author":"JH Butt","year":"2022","unstructured":"Butt JH, Jhund PS, Belohlavek J, de Boer RA, Chiang CE, Desai AS, et al. Efficacy and safety of dapagliflozin according to frailty in patients with heart failure: a prespecified analysis of the DELIVER Trial. Circulation. 2022;146(16):1210\u201324.","journal-title":"Circulation"},{"issue":"3","key":"1121_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/2048872615581502","volume":"5","author":"HD White","year":"2016","unstructured":"White HD, Westerhout CM, Alexander KP, Roe MT, Winters KJ, Cyr DD, et al. Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Eur Heart J Acute Cardiovasc Care. 2016;5(3):231\u201342.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"10","key":"1121_CR42","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamacardio.2023.1634","volume":"8","author":"DH Kim","year":"2023","unstructured":"Kim DH, Zhong L, Rich MW. Frailty-guided management of cardiovascular disease-from clinical trials to clinical practice. JAMA Cardiol. 2023;8(10):897\u20138.","journal-title":"JAMA Cardiol."},{"key":"1121_CR43","doi-asserted-by":"publisher","unstructured":"Shi SM, McCarthy EP, Mitchell S, Kim DH. Changes in predictive performance of a frailty index with availability of clinical domains. J Am Geriatr Soc. 2020;68(8):1771\u20131777. https:\/\/doi.org\/10.1111\/jgs.16436. Epub 2020\nApr 10. PMID: 32274807; PMCID: PMC7872739.","DOI":"10.1111\/jgs.16436"},{"key":"1121_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.arr.2015.04.001","volume":"21","author":"O Theou","year":"2015","unstructured":"Theou O, Cann L, Blodgett J, Wallace LM, Brothers TD, Rockwood K. Modifications to the frailty phenotype criteria: Systematic review of the current literature and investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and Retirement in Europe. Ageing Res Rev. 2015;21:78\u201394.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1121_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamainternmed.2023.0047","volume":"183","author":"J Sanchis","year":"2023","unstructured":"Sanchis J, Bueno H, Minana G, Guerrero C, Marti D, Martinez-Selles M, et al. Effect of routine invasive vs conservative strategy in older adults with frailty and non-ST-segment elevation acute myocardial infarction: a randomized clinical trial. JAMA Intern Med. 2023;183(5):407\u201315.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1121_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/cpt.359","volume":"100","author":"KJ Lin","year":"2016","unstructured":"Lin KJ, Schneeweiss S. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs. Clin Pharmacol Ther. 2016;100(2):147\u201359.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1121_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1592\/phco.29.2.138","volume":"29","author":"SE Harpe","year":"2009","unstructured":"Harpe SE. Using secondary data sources for pharmacoepidemiology and outcomes research. Pharmacotherapy. 2009;29(2):138\u201353.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1121_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jgo.2012.12.005","volume":"4","author":"AJ Davidoff","year":"2013","unstructured":"Davidoff AJ, Zuckerman IH, Pandya N, Hendrick F, Ke X, Hurria A, et al. A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes. J Geriatr Oncol. 2013;4(2):157\u201365.","journal-title":"J Geriatr Oncol."},{"issue":"1","key":"1121_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/pds.3719","volume":"24","author":"KR Faurot","year":"2015","unstructured":"Faurot KR, Jonsson Funk M, Pate V, Brookhart MA, Patrick A, Hanson LC, et al. Using claims data to predict dependency in activities of daily living as a proxy for frailty. Pharmacoepidemiol Drug Saf. 2015;24(1):59\u201366.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1121_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","volume":"55","author":"JB Segal","year":"2017","unstructured":"Segal JB, Chang HY, Du Y, Walston JD, Carlson MC, Varadhan R. Development of a claims-based frailty indicator anchored to a well-established frailty phenotype. Med Care. 2017;55(7):716\u201322.","journal-title":"Med Care"},{"issue":"10","key":"1121_CR51","doi-asserted-by":"publisher","first-page":"706","DOI":"10.7326\/M17-0767","volume":"167","author":"JF Figueroa","year":"2017","unstructured":"Figueroa JF, Joynt Maddox KE, Beaulieu N, Wild RC, Jha AK. Concentration of potentially preventable spending among high-cost Medicare subpopulations: an observational study. Ann Intern Med. 2017;167(10):706\u201313.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1121_CR52","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring frailty in medicare data: development and validation of a claims-based frailty index. J Gerontol A Biol Sci Med Sci. 2018;73(7):980\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"8","key":"1121_CR53","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/gerona\/gly232","volume":"74","author":"AR Orkaby","year":"2019","unstructured":"Orkaby AR, Nussbaum L, Ho YL, Gagnon D, Quach L, Ward R, et al. The burden of frailty among U.S. veterans and its association with mortality, 2002\u20132012. J Gerontol A Biol Sci Med Sci. 2019;74(8):1257\u201364.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10132","key":"1121_CR54","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","volume":"391","author":"T Gilbert","year":"2018","unstructured":"Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391(10132):1775\u201382.","journal-title":"Lancet"},{"issue":"3","key":"1121_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/afw039","volume":"45","author":"A Clegg","year":"2016","unstructured":"Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353\u201360.","journal-title":"Age Ageing"},{"issue":"6","key":"1121_CR56","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/gerona\/glz224","volume":"75","author":"DH Kim","year":"2020","unstructured":"Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the U.S. Medicare data. J Gerontol A Biol Sci Med Sci. 2020;75(6):1120\u20135.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"1121_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/ageing\/afy162","volume":"48","author":"C Brundle","year":"2019","unstructured":"Brundle C, Heaven A, Brown L, Teale E, Young J, West R, Clegg A. Convergent validity of the electronic frailty index. Age Ageing. 2019;48(1):152\u20136.","journal-title":"Age Ageing"},{"issue":"1","key":"1121_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12877-020-01739-w","volume":"20","author":"N Festa","year":"2020","unstructured":"Festa N, Shi SM, Kim DH. Accuracy of diagnosis and health service codes in identifying frailty in Medicare data. BMC Geriatr. 2020;20(1):329.","journal-title":"BMC Geriatr"},{"issue":"12","key":"1121_CR59","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1111\/jgs.18540","volume":"71","author":"C DuMontier","year":"2023","unstructured":"DuMontier C, Hennis R, Yilidirim C, Seligman BJ, Fonseca Valencia C, Lubinski BL, et al. Construct validity of the electronic Veterans Affairs Frailty Index against clinician frailty assessment. J Am Geriatr Soc. 2023;71(12):3857\u201364.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1121_CR60","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/EDE.0000000000000833","volume":"29","author":"CC Cuthbertson","year":"2018","unstructured":"Cuthbertson CC, Kucharska-Newton A, Faurot KR, Sturmer T, Jonsson Funk M, Palta P, et al. Controlling for frailty in pharmacoepidemiologic studies of older adults: validation of an existing medicare claims-based algorithm. Epidemiology. 2018;29(4):556\u201361.","journal-title":"Epidemiology"},{"issue":"6","key":"1121_CR61","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/aje\/kwx257","volume":"186","author":"JB Segal","year":"2017","unstructured":"Segal JB, Huang J, Roth DL, Varadhan R. External validation of the claims-based frailty index in the national health and aging trends study cohort. Am J Epidemiol. 2017;186(6):745\u20137.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"1121_CR62","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/gerona\/gly197","volume":"74","author":"DH Kim","year":"2019","unstructured":"Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, Schneeweiss S. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. J Gerontol A Biol Sci Med Sci. 2019;74(8):1271\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1121_CR63","doi-asserted-by":"publisher","unstructured":"Turcotte LA, Heckman G, Rockwood K, Vetrano DL, Hebert P, McIsaac DI, et al. External validation of the hospital frailty risk score among hospitalised home care clients in Canada: a retrospective cohort study. Age Ageing. 2023;52(2):afac334. https:\/\/doi.org\/10.1093\/ageing\/afac334. PMID: 36735847; PMCID: PMC9897298.","DOI":"10.1093\/ageing\/afac334"},{"issue":"1\u20132","key":"1121_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.hjdsi.2016.11.002","volume":"5","author":"KE Joynt","year":"2017","unstructured":"Joynt KE, Figueroa JF, Beaulieu N, Wild RC, Orav EJ, Jha AK. Segmenting high-cost Medicare patients into potentially actionable cohorts. Healthc (Amst). 2017;5(1\u20132):62\u20137.","journal-title":"Healthc (Amst)."},{"issue":"6","key":"1121_CR65","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ageing\/afz110","volume":"48","author":"J Hollinghurst","year":"2019","unstructured":"Hollinghurst J, Fry R, Akbari A, Clegg A, Lyons RA, Watkins A, Rodgers SE. External validation of the electronic Frailty Index using the population of Wales within the Secure Anonymised Information Linkage Databank. Age Ageing. 2019;48(6):922\u20136.","journal-title":"Age Ageing"},{"issue":"5","key":"1121_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MLR.0000000000001994","volume":"62","author":"ED Duchesneau","year":"2024","unstructured":"Duchesneau ED, Sturmer T, Kim DH, Reeder-Hayes K, Edwards JK, Faurot KR, Lund JL. Performance of a claims-based frailty proxy using varying frailty ascertainment lookback windows. Med Care. 2024;62(5):305\u201313.","journal-title":"Med Care"},{"key":"1121_CR67","doi-asserted-by":"publisher","unstructured":"Sison SDM, Shi SM, Oh G, Jeong S, McCarthy EP, Kim DH. Claims-based frailty index and its relationship with commonly used clinical frailty measures. J Gerontol A Biol Sci Med Sci. 2024:glae094. https:\/\/doi.org\/10.1093\/gerona\/glae094. Epub ahead of print. PMID: 38557604","DOI":"10.1093\/gerona\/glae094"},{"key":"1121_CR68","first-page":"1472","volume":"2013","author":"NG Weiskopf","year":"2013","unstructured":"Weiskopf NG, Rusanov A, Weng C. Sick patients have more data: the non-random completeness of electronic health records. AMIA Annu Symp Proc. 2013;2013:1472\u20137.","journal-title":"AMIA Annu Symp Proc"},{"key":"1121_CR69","doi-asserted-by":"publisher","unstructured":"Shi SM, Steinberg N, Oh G, Olivieri-Mui B, Sison S, McCarthy EP, Kim DH. Change in a claims-based frailty index, mortality, and healthcare costs in medicare beneficiaries. J Gerontol A Biol Sci Med Sci. 2023;78(7):1198-1203. https:\/\/doi.org\/10.1093\/gerona\/glad010. Erratum in: J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2185. PMID: 36630699; PMCID: PMC10329229","DOI":"10.1093\/gerona\/glad010"},{"issue":"4","key":"1121_CR70","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323\u201337.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"1121_CR71","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/gerona\/glz017","volume":"74","author":"NM Pajewski","year":"2019","unstructured":"Pajewski NM, Lenoir K, Wells BJ, Williamson JD, Callahan KE. Frailty screening using the electronic health record within a medicare accountable care organization. J Gerontol A Biol Sci Med Sci. 2019;74(11):1771\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"1121_CR72","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cpt.861","volume":"103","author":"KJ Lin","year":"2018","unstructured":"Lin KJ, Singer DE, Glynn RJ, Murphy SN, Lii J, Schneeweiss S. Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data. Clin Pharmacol Ther. 2018;103(5):899\u2013905.","journal-title":"Clin Pharmacol Ther"},{"key":"1121_CR73","unstructured":"The National Health Service in England. Supporting routine frailty identification and frailty through the GP Contract 2017\/2018. Available at: https:\/\/www.england.nhs.uk\/publication\/supporting-routine-frailty-identification-and-frailty-through-the-gp-contract-20172018\/. Accessed 3 May 2024"},{"issue":"12","key":"1121_CR74","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/pds.4298","volume":"26","author":"HT Zhang","year":"2017","unstructured":"Zhang HT, McGrath LJ, Wyss R, Ellis AR, Sturmer T. Controlling confounding by frailty when estimating influenza vaccine effectiveness using predictors of dependency in activities of daily living. Pharmacoepidemiol Drug Saf. 2017;26(12):1500\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1121_CR75","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/aje\/kwz083","volume":"188","author":"HT Zhang","year":"2019","unstructured":"Zhang HT, McGrath LJ, Ellis AR, Wyss R, Lund JL, Sturmer T. Restriction of pharmacoepidemiologic cohorts to initiators of medications in unrelated preventive drug classes to reduce confounding by frailty in older adults. Am J Epidemiol. 2019;188(7):1371\u201382.","journal-title":"Am J Epidemiol"},{"issue":"10 Suppl 2","key":"1121_CR76","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1097\/MLR.0b013e318070c08e","volume":"45","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Patrick AR, Sturmer T, Brookhart MA, Avorn J, Maclure M, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007;45(10 Suppl 2):S131\u201342.","journal-title":"Med Care"},{"issue":"4","key":"1121_CR77","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","volume":"20","author":"S Schneeweiss","year":"2009","unstructured":"Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512\u201322.","journal-title":"Epidemiology"},{"issue":"3","key":"1121_CR78","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/aje\/kwi192","volume":"162","author":"T Sturmer","year":"2005","unstructured":"Sturmer T, Schneeweiss S, Avorn J, Glynn RJ. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol. 2005;162(3):279\u201389.","journal-title":"Am J Epidemiol"},{"issue":"10 Supl 2","key":"1121_CR79","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/MLR.0b013e318070c045","volume":"45","author":"T Sturmer","year":"2007","unstructured":"Sturmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information. Med Care. 2007;45(10 Supl 2):S158\u201365.","journal-title":"Med Care"},{"issue":"1","key":"1121_CR80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/01.ede.0000147164.11879.b5","volume":"16","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Glynn RJ, Tsai EH, Avorn J, Solomon DH. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology. 2005;16(1):17\u201324.","journal-title":"Epidemiology"},{"issue":"4","key":"1121_CR81","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.7326\/M20-7141","volume":"179","author":"DH Kim","year":"2021","unstructured":"Kim DH, Pawar A, Gagne JJ, Bessette LG, Lee H, Glynn RJ, Schneeweiss S. Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study. Ann Intern Med. 2021;179(4):1214\u201323.","journal-title":"Ann Intern Med"},{"issue":"11","key":"1121_CR82","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.42264","volume":"6","author":"KJ Lin","year":"2023","unstructured":"Lin KJ, Singer DE, Ko D, Glynn R, Najafzadeh M, Lee SB, et al. Frailty, home time, and health care costs in older adults with atrial fibrillation receiving oral anticoagulants. JAMA Netw Open. 2023;6(11): e2342264.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1121_CR83","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jamainternmed.2023.1667","volume":"183","author":"TS Anderson","year":"2023","unstructured":"Anderson TS, Herzig SJ, Jing B, Boscardin WJ, Fung K, Marcantonio ER, Steinman MA. Clinical outcomes of intensive inpatient blood pressure management in hospitalized older adults. JAMA Intern Med. 2023;183(7):715\u201323.","journal-title":"JAMA Intern Med"},{"key":"1121_CR84","doi-asserted-by":"publisher","unstructured":"Orkaby AR, Lu B, Ho YL, Treu T, Galloway A, Wilson PWF, et al. New statin use, mortality, and first cardiovascular events in older US Veterans by frailty status. J Am Geriatr Soc. 2024;72(2):410\u2013422. https:\/\/doi.org\/10.1111\/jgs.18700. Epub 2023 Dec 15.\nPMID: 38055194; PMCID: PMC10922314.","DOI":"10.1111\/jgs.18700"},{"issue":"4","key":"1121_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004223","volume":"20","author":"JP Sheppard","year":"2023","unstructured":"Sheppard JP, Koshiaris C, Stevens R, Lay-Flurrie S, Banerjee A, Bellows BK, et al. The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study. PLoS Med. 2023;20(4): e1004223.","journal-title":"PLoS Med"},{"issue":"4","key":"1121_CR86","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7326\/M18-3136","volume":"171","author":"CV Dave","year":"2019","unstructured":"Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Sodium-glucose cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study. Ann Intern Med. 2019;171(4):248\u201356.","journal-title":"Ann Intern Med"},{"issue":"10","key":"1121_CR87","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.30762","volume":"4","author":"M Zhuo","year":"2021","unstructured":"Zhuo M, Hawley CE, Paik JM, Bessette LG, Wexler DJ, Kim DH, et al. Association of sodium-glucose cotransporter-2 inhibitors with fracture risk in older adults with type 2 diabetes. JAMA Netw Open. 2021;4(10): e2130762.","journal-title":"JAMA Netw Open"},{"issue":"12","key":"1121_CR88","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1093\/gerona\/glad075","volume":"78","author":"PT Htoo","year":"2023","unstructured":"Htoo PT, Paik JM, Alt E, Kim DH, Wexler DJ, Kim SC, Patorno E. Risk of severe hypoglycemia with newer second-line glucose-lowering medications in older adults with type 2 diabetes stratified by known indicators of hypoglycemia risk. J Gerontol A Biol Sci Med Sci. 2023;78(12):2426\u201334.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"1121_CR89","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.2337\/dc23-0671","volume":"46","author":"A Kutz","year":"2023","unstructured":"Kutz A, Kim DH, Wexler DJ, Liu J, Schneeweiss S, Glynn RJ, Patorno E. Comparative cardiovascular effectiveness and safety of SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 Inhibitors according to frailty in type 2 diabetes. Diabetes Care. 2023;46(11):2004\u201314.","journal-title":"Diabetes Care"},{"issue":"20","key":"1121_CR90","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1182\/bloodadvances.2023011019","volume":"7","author":"C DuMontier","year":"2023","unstructured":"DuMontier C, La J, Bihn J, Corrigan J, Yildirim C, Dharne M, et al. More intensive therapy has a better effect for frail parents with multiple myeloma. Blood Adv. 2023;7(20):6275\u201384.","journal-title":"Blood Adv"},{"issue":"5","key":"1121_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2023.101520","volume":"14","author":"ES Deol","year":"2023","unstructured":"Deol ES, Sanfilippo KM, Luo S, Fiala MA, Wildes T, Mian H, Schoen MW. Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer. J Geriatr Oncol. 2023;14(5): 101520.","journal-title":"J Geriatr Oncol."},{"issue":"3","key":"1121_CR92","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/pds.4385","volume":"27","author":"CJ Maxwell","year":"2018","unstructured":"Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, et al. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition. Pharmacoepidemiol Drug Saf. 2018;27(3):289\u201398.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"1121_CR93","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.26852","volume":"6","author":"DA Harris","year":"2023","unstructured":"Harris DA, Hayes KN, Zullo AR, Mor V, Chachlani P, Deng Y, et al. Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older US adults. JAMA Netw Open. 2023;6(8): e2326852.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1121_CR94","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/aje\/kwy049","volume":"187","author":"SV Wang","year":"2018","unstructured":"Wang SV, Jin Y, Fireman B, Gruber S, He M, Wyss R, et al. Relative performance of propensity score matching strategies for subgroup analyses. Am J Epidemiol. 2018;187(8):1799\u2013807.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1121_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5716","volume":"33","author":"PT Htoo","year":"2024","unstructured":"Htoo PT, Glynn RJ, Wang S, Paik JM, Schneeweiss S, Walker AM, Patorno E. Stratified analysis in comparative effectiveness studies that emulate randomized trials. Pharmacoepidemiol Drug Saf. 2024;33(1): e5716.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1121_CR96","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/EDE.0b013e3181f74493","volume":"22","author":"TJ Vanderweele","year":"2011","unstructured":"Vanderweele TJ, Arah OA. Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders. Epidemiology. 2011;22(1):42\u201352.","journal-title":"Epidemiology"},{"issue":"5","key":"1121_CR97","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pds.1200","volume":"15","author":"S Schneeweiss","year":"2006","unstructured":"Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf. 2006;15(5):291\u2013303.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1121_CR98","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1121_CR99","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cpt.2452","volume":"112","author":"Q Liu","year":"2022","unstructured":"Liu Q, Schwartz JB, Slattum PW, Lau SWJ, Guinn D, Madabushi R, et al. Roadmap to 2030 for drug evaluation in older adults. Clin Pharmacol Ther. 2022;112(2):210\u201323.","journal-title":"Clin Pharmacol Ther"},{"key":"1121_CR100","unstructured":"European Medicines Agency, Committee for Human Medicinal Products. Reflection paper on physical frailty: instruments for baseline characterisation of older populations in clinical trials. Jan 9, 2018. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-physical-frailty-instruments-baseline-characterisation-older-populations-clinical_en.pdf Accessed 5 May 2024."},{"key":"1121_CR101","unstructured":"The United States Food and Drug Administration. Enhancing the diversity of clinical trial populations \u2014 eligibility criteria, enrollment practices, and trial designs guidance for industry. November 2020. Available at: https:\/\/www.fda.gov\/media\/127712\/download. Accessed 5 May 2024."},{"key":"1121_CR102","unstructured":"The United States Food and Drug Administration. Inclusion of Older Adults in Cancer Clinical Trials \u2014 Guidance for Industry. March 2022. Available at: https:\/\/www.fda.gov\/media\/156616\/download. Accessed 5 May 2024."},{"issue":"8","key":"1121_CR103","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/jgs.15411","volume":"66","author":"H Kharrazi","year":"2018","unstructured":"Kharrazi H, Anzaldi LJ, Hernandez L, Davison A, Boyd CM, Leff B, et al. The value of unstructured electronic health record data in geriatric syndrome case identification. J Am Geriatr Soc. 2018;66(8):1499\u2013507.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1121_CR104","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12877-017-0645-7","volume":"17","author":"LJ Anzaldi","year":"2017","unstructured":"Anzaldi LJ, Davison A, Boyd CM, Leff B, Kharrazi H. Comparing clinician descriptions of frailty and geriatric syndromes using electronic health records: a retrospective cohort study. BMC Geriatr. 2017;17(1):248.","journal-title":"BMC Geriatr"},{"key":"1121_CR105","first-page":"1110","volume":"2016","author":"Y Shao","year":"2016","unstructured":"Shao Y, Mohanty AF, Ahmed A, Weir CR, Bray BE, Shah RU, et al. Identification and use of frailty indicators from text to examine associations with clinical outcomes among patients with heart failure. AMIA Annu Symp Proc. 2016;2016:1110\u20138.","journal-title":"AMIA Annu Symp Proc"},{"issue":"1","key":"1121_CR106","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12891-020-03522-9","volume":"21","author":"RN Moorthi","year":"2020","unstructured":"Moorthi RN, Liu Z, El-Azab SA, Lembcke LR, Miller MR, Broyles AA, Imel EA. Sarcopenia, frailty and cachexia patients detected in a multisystem electronic health record database. BMC Musculoskelet Disord. 2020;21(1):508.","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"1121_CR107","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/gerona\/glad157","volume":"78","author":"AR Orkaby","year":"2023","unstructured":"Orkaby AR, Huan T, Intrator O, Cai S, Schwartz AW, Wieland D, et al. Comparison of claims-based frailty indices in U.S. veterans 65 and older for prediction of long-term institutionalization and mortality. J Gerontol A Biol Sci Med Sci. 2023;78(11):2136\u201344.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"12","key":"1121_CR108","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.121.008566","volume":"14","author":"JB Strom","year":"2021","unstructured":"Strom JB, Xu J, Orkaby AR, Shen C, Song Y, Charest BR, et al. Role of frailty in identifying benefit from transcatheter versus surgical aortic valve replacement. Circ Cardiovasc Qual Outcomes. 2021;14(12): e008566.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"1121_CR109","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/aje\/kwx164","volume":"186","author":"D Westreich","year":"2017","unstructured":"Westreich D, Edwards JK, Lesko CR, Stuart E, Cole SR. Transportability of trial results using inverse odds of sampling weights. Am J Epidemiol. 2017;186(8):1010\u20134.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"1121_CR110","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/EDE.0000000000001231","volume":"31","author":"IJ Dahabreh","year":"2020","unstructured":"Dahabreh IJ, Robins JM, Hernan MA. Benchmarking observational methods by comparing randomized trials and their emulations. Epidemiology. 2020;31(5):614\u20139.","journal-title":"Epidemiology"},{"issue":"4","key":"1121_CR111","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/cpt.2983","volume":"114","author":"H Shin","year":"2023","unstructured":"Shin H, Wang SV, Kim DH, Alt E, Mahesri M, Bessette LG, et al. Predicting Treatment effects of a new-to-market drug in clinical practice based on phase III randomized trial results. Clin Pharmacol Ther. 2023;114(4):853\u201361.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1121_CR112","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/EDE.0000000000001230","volume":"31","author":"M Webster-Clark","year":"2020","unstructured":"Webster-Clark M, Lund JL, Sturmer T, Poole C, Simpson RJ, Edwards JK. Reweighting oranges to apples: transported RE-LY trial versus nonexperimental effect estimates of anticoagulation in atrial fibrillation. Epidemiology. 2020;31(5):605\u201313.","journal-title":"Epidemiology"},{"key":"1121_CR113","unstructured":"The U.S. Food and Drug Administration Sentinel Initiative. Available from: https:\/\/www.sentinelinitiative.org. Accessed 3 May 2024"},{"issue":"12","key":"1121_CR114","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/pds.1509","volume":"16","author":"JS Brown","year":"2007","unstructured":"Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007;16(12):1275\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"1121_CR115","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/pds.3616","volume":"23","author":"JJ Gagne","year":"2014","unstructured":"Gagne JJ, Wang SV, Rassen JA, Schneeweiss S. A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment. Pharmacoepidemiol Drug Saf. 2014;23(6):619\u201327.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"1121_CR116","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jval.2015.08.011","volume":"18","author":"JJ Gagne","year":"2015","unstructured":"Gagne JJ, Bykov K, Najafzadeh M, Choudhry NK, Martin DP, Kahler KH, et al. Prospective benefit-risk monitoring of new drugs for rapid assessment of net favorability in electronic health care data. Value Health. 2015;18(8):1063\u20139.","journal-title":"Value Health."},{"issue":"3","key":"1121_CR117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40264-014-0136-0","volume":"37","author":"JJ Gagne","year":"2014","unstructured":"Gagne JJ, Rassen JA, Choudhry NK, Bohn RL, Patrick AR, Sridhar G, et al. Near-real-time monitoring of new drugs: an application comparing prasugrel versus clopidogrel. Drug Saf. 2014;37(3):151\u201361.","journal-title":"Drug Saf"},{"issue":"1","key":"1121_CR118","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/clpt.2011.369","volume":"92","author":"JJ Gagne","year":"2012","unstructured":"Gagne JJ, Glynn RJ, Rassen JA, Walker AM, Daniel GW, Sridhar G, Schneeweiss S. Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system. Clin Pharmacol Ther. 2012;92(1):80\u20136.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"1121_CR119","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005173","volume":"12","author":"S Schneeweiss","year":"2019","unstructured":"Schneeweiss S, Gopalakrishnan C, Bartels DB, Franklin JM, Zint K, Kulldorff M, Huybrechts KF. Sequential monitoring of the comparative effectiveness and safety of dabigatran in routine care. Circ Cardiovasc Qual Outcomes. 2019;12(2): e005173.","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01121-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01121-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T06:32:04Z","timestamp":1721025124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01121-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01121-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"7 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The work reported in this publication was supported by the National Institute on Aging of the National Institutes of Health under Award Number K08AG051187, R01AG062713, R01AG071809, and K24AG073527. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"D.H.K. receives grants from the National Institutes of Health for unrelated work. He received personal fees from Alosa Health and VillageMD.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable to this review article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All authors have read and approve the final version of the manuscript and agree to be accountable for the work. Concept and design: D.H.K. Acquisition, analysis, and interpretation of data: D.H.K., C.M.P., D.K., K.J.L., and R.J.G. Drafting of the manuscript: D.H.K. and C.M.P. Critical review of the manuscript for important intellectual content: D.H.K., C.M.P., D.K., K.J.L., and R.J.G. Obtained funding: D.H.K. Administrative, technical, or material support: D.H.K. and C.M.P. Supervision: D.H.K.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}